Zoetis disclosed Q1 2026 revenue of $2.3 billion in its SEC 8-K filing. Adjusted earnings per share (EPS) came in at $1.53, falling short of Wall Street consensus of $1.60.
📊 Stock Price at Report Time (May 7, 2026, 9:02 p.m. KST)
$111.22 ▼ -1.17%
₩161,380 (1451 KRW/USD)
Q1 Performance Overview
Zoetis' first-quarter revenue grew 3% year-over-year. However, declining pet owner spending and intensifying competition weighed heavily on U.S. results. Net income remained flat at $601 million compared to the prior year period.
- Revenue: $2.3 billion, +3% YoY
- Net Income: $601 million, flat YoY
- Reported EPS: $1.42, +6% YoY
- Adjusted EPS: $1.53, missed consensus of $1.60
- Adjusted Net Income: $646 million, +2% YoY
2026 Guidance
Zoetis revised its 2026 full-year revenue guidance to $9.68 billion–$9.96 billion, with organic growth projected at 2–5%. Adjusted EPS guidance was also narrowed to $6.85–$7.00.
CEO Kristin Peck noted that "pet owners are demonstrating heightened price sensitivity, resulting in reduced veterinary visits and softening demand for premium products." She added, "We remain confident in our ability to drive sustained value creation, underpinned by more than 12 potential blockbuster pipeline candidates and our diversified business portfolio."
Market Reaction
Zoetis shares declined 1.17% to $111.22 as of 9:02 p.m. KST on May 7, 2026. Reports attributed the sell-off to both lower-than-expected guidance and earnings disappointment. The adjusted EPS of $1.53 fell short of the FactSet consensus estimate of $1.60.
Business Segment Performance
- U.S. Revenue: $1.1 billion, -8% YoY | Pet Products -11%, Livestock Products +7%
- International Revenue: $1.1 billion, +17% reported, +10% organic | Pet Products +15%, Livestock Products +19%
- International segment benefited from approximately $100 million in timing-related pricing benefits from select markets
This article was automatically generated based on SEC 8-K filings and press reports, intended for rapid dissemination of key data following announcement. Investors are advised to review official company disclosures before making trading decisions. Stock prices reflect the time of publication and may differ from current levels.
